Patent application number | Description | Published |
20110093930 | Concept of Efficiently Distributing Access Authorization Information - A device for controlling a service access authorization for a user device with regard to an access-restricted service includes a service access authorization provider, the service access authorization provider being configured to set a period of time in which the service access authorization is valid, responsive to an authorization message provided with a service-dependent user identifier, and the service access authorization provider being configured to disable an authorization allowing the service access authorization to be extended or reactivated using the previous service-dependent user identifier when at least a predetermined duration has passed since an end of a last authorization time interval for which a service access authorization was determined by the device. | 04-21-2011 |
20130152121 | TRANSPORT-STREAM PROVIDER, DAB SIGNAL PROVIDER, TRANSPORT STREAM ANALYZER, DAB RECEIVER, METHOD, COMPUTER PROGRAM, AND TRANSPORT STREAM SIGNAL - A transport stream provider for providing a plurality of transport stream packets describing digital media information is configured to provide a transport stream packet of a first packet type including a program association table and key information for decrypting encrypted media information. The program association table contains an association between a program No. and a packet type identifier of a further transport stream packet of a second packet type. The transport stream provider is configured to provide a transport stream packet of the second packet type in such a manner that the transport stream packet of the second packet type contains a reference to packet type identifiers of transport stream payload data packets which describe contents of different content types of the digital media information. | 06-13-2013 |
20140310740 | TRANSPORT STREAM PROVIDER, DAB SIGNAL PROVIDER, TRANSPORT STREAM ANALYZER, DAB RECEIVER, METHOD, COMPUTER PROGRAM, AND TRANSPORT STREAM SIGNAL - A transport stream provider for providing a plurality of transport stream packets describing digital media information is configured to provide a transport stream packet of a first packet type including a program association table and key information for decrypting encrypted media information. The program association table contains an association between a program No. and a packet type identifier of a further transport stream packet of a second packet type. The transport stream provider is configured to provide a transport stream packet of the second packet type in such a manner that the transport stream packet of the second packet type contains a reference to packet type identifiers of transport stream payload data packets which describe contents of different content types of the digital media information. | 10-16-2014 |
Patent application number | Description | Published |
20100254988 | Bispecific Anti ErbB2 / Anti cMet Antibodies - The present invention relates to bispecific antibodies against human ErbB-2 and against human c-Met, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof. | 10-07-2010 |
20100254989 | Bispecific Anti ErbB1 / Anti c Met Antibodies - The present invention relates to bispecific antibodies against human ErbB-1 and against human c-Met, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof. | 10-07-2010 |
20110052582 | Humanized Anti-CDCP1 Antibodies - The present invention relates to humanized antibodies against human CDCP1 (anti-CDCP1 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 03-03-2011 |
20110070246 | Antibodies Against CDCP1 for the Treatment of Cancer - The present invention relates to antibodies against human CDCP1 binding to the same epitope as CUB4 (Deposition No. DSM ACC2551) for the treatment of cancer. | 03-24-2011 |
20110117096 | Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies - Tumors are identified as responsive to treatment with anti-HER2 antibodies by detecting the presence of a HER2/HER3 and/or HER2/HER1 protein complex or for HER2 phosphorylation in a sample of tumor cells. Patients suffering from a tumor comprising HER/2/HER1 and/or HER2/HER3 heterodimers and/or HER2 phosphorylation are treated with anti-HER2 antibodies, such as rhuMAb 2C4. | 05-19-2011 |
20110165082 | METHOD FOR DETERMINING THE ANTI-TUMOR EFFICACY OF MONOCLONAL ANTIBODIES - The present invention relates to a method for determining the anti-tumor efficacy of monoclonal antibodies in pre-clinical rodent testings and the use of said method for the reduction of side testings. | 07-07-2011 |
20110171222 | ANTI-HER3 ANTIBODIES AND USES THEREOF - The present invention relates to antibodies binding to human HER3 (anti-HER3 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 07-14-2011 |
20120237506 | Antigen Binding Proteins - The present invention relates to antigen binding proteins comprising two Fc parts, methods for their production, pharmaceutical compositions containing said antigen binding proteins, and uses thereof. | 09-20-2012 |
20120237507 | Monovalent Antigen Binding Proteins - The present invention relates to monovalent antigen binding proteins with a CH1-CL domain exchange, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 09-20-2012 |
20130156772 | Bispecific Anti ErbB1 / Anti cMet Antibodies - The present invention relates to bispecific antibodies against human ErbB-1 and against human c-Met, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof. | 06-20-2013 |
20130209455 | Humanized Anti-CDCP1 Antibodies - The present invention relates to humanized antibodies against human CDCP1 (anti-CDCP1 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 08-15-2013 |
20130273054 | Bispecific Anti ErbB2/Anti cMet Antibodies - The present invention relates to bispecific antibodies against human ErbB-2 and against human C-met, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof. | 10-17-2013 |
20140135482 | Bispecific Anti ErbB3 / Anti cMet Antibodies - The present invention relates to bispecific antibodies against human ErbB-3 and against human c-Met, methods for their production, pharmaceutical compositions containing the antibodies, and uses thereof. | 05-15-2014 |
20140186354 | ANTI-HER3/HER4 ANTIBODIES BINDING TO THE BETA-HAIRPIN OF HER3 AND THE BETA-HAIRPIN OF HER4 - The invention relates to anti-HER3/HER4 antigen binding proteins, e.g. anti-HER3/HER4 antibodies, that bind to the beta-hairpin of HER3 and the beta-hairpin of HER4, methods for selecting these antigen binding proteins, their preparation and use as medicament. | 07-03-2014 |
20140186358 | HER3 ANTIBODIES BINDING TO THE BETA-HAIRPIN OF HER3 - The invention relates to anti-HER3 antigen binding proteins, e.g. anti-HER3 antibodies, that bind to the beta-hairpin of HER3, methods for selecting these antigen binding proteins, their preparation and use as medicament. | 07-03-2014 |
20140377272 | ANTI-HER3 ANTIBODIES AND USES THEREOF - The present invention relates to antibodies binding to human HER3 (anti-HER3 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 12-25-2014 |
20140377273 | ANTI-HER3 ANTIBODIES AND USES THEREOF - The present invention relates to antibodies binding to human HER3 (anti-HER3 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 12-25-2014 |
Patent application number | Description | Published |
20090180873 | Armor-Plated Machine Components and Gas Turbines - The invention relates to a machine component with a base made of a base material, a part of the surface of which has been equipped with armor-plating, made of a plating material with greater hardness in comparison to the base material, with the armor-plating being segmented and made up of a number of armor-plating segments. | 07-16-2009 |
20100116793 | Welded Repair of Defects Lying on the Inside of Components - The repair of cracks according to the state of the art comprises the fact that defects located on the inside must be worked outward in order to be able to be welded closed. The method according to the invention proposes not to work out cracks located on the inside, but to melt the crack located on the inside utilizing a flux agent. | 05-13-2010 |
20100224600 | TWO-STEP WELDING PROCESS - A welding process is provided. The welding process includes two steps. First, the welding material is applied over a large area of the substrate in the region without melting or partially melting the welding material. Then, a welding device is used to melt the applied welding material. In addition the welding material may be applied in two applications where the second application of the welding material is applied over a large area of the first application of molten and solidified welding material. Then, the second application of the welding material is melted. | 09-09-2010 |
20100269510 | Machine Component and Gas Turbine - A machine component including a base body produced from a base material is provided. The base body is equipped in a partial region of the surface thereof with a plating made of an application material having a greater hardness and/or viscosity as compared to the base material. The plating is foamed by a number of plating elements that are applied to the base body in the longitudinal direction thereof in a tilted manner relative to the main flow direction of a hot gas flowing through the base body. | 10-28-2010 |
20110088482 | Material for tensile and HCF tests for the testing of buildup welds and method - A material specimen is provided. The material specimen for tensile or HCF tests includes two welds arranged opposite one another on the specimen which do not touch. The welds are arranged symmetrically in relation to a plane or mirror symmetrically in relation to a longitudinal axis of the specimen which extends parallel to the line of effective force. | 04-21-2011 |
20120107136 | SEALING PLATE AND ROTOR BLADE SYSTEM - A rotor blade system, for example, of a gas turbine is provided. The rotor blade system includes a plurality of rotor blades which are arranged annularly on a rotor disk. A plurality of sealing plates are arranged on a side surface of the rotor disk. An individual sealing plate is formed from a plurality of metal sheets, wherein two of the metal sheets are arranged opposite each other a distance apart and parallel to a plane of the sealing plate, forming a gap for guiding of cooling air. | 05-03-2012 |
20120118860 | Method for the welding production of a large-dimensioned part from ductile iron by using laser-deposition-welded buffer materials and electric welding - A method for producing a part from ductile iron, including the steps of designing the part in such a way that the part is composed of a plurality of part components, producing the part components from ductile iron, providing the part components in pairs, depositing buffer material onto the rim edge of the first part component and onto the rim edge of the second part component by means of deposition welding, laying the second part component with the rim section thereof on the rim section of the first part component so that the rim edges lie against each other with the buffer materials thereof, and welding the rim sections, wherein the buffer material is selected in such a way that a structure change in the ductile iron material of the part components is prevented when the rim sections are welded. | 05-17-2012 |
Patent application number | Description | Published |
20090041953 | Method for depositing a metallic substrate on a wall - In one aspect, a method for depositing a metallic substrate on a wall of a narrow depression of a metallic component is provided. A wire electrode is introduced into the depression and thereby bent in the direction of the wall by means of a guide. A suitable voltage is applied to the component and to the wire electrode in order to create an arc, which melts the wire electrode in certain regions. The molten material of the wire electrode is thereby deposited on the wall of the component. The wire electrode is progressively fed in during the depositing operation. | 02-12-2009 |
20090180873 | Armor-Plated Machine Components and Gas Turbines - The invention relates to a machine component with a base made of a base material, a part of the surface of which has been equipped with armor-plating, made of a plating material with greater hardness in comparison to the base material, with the armor-plating being segmented and made up of a number of armor-plating segments. | 07-16-2009 |
20100116793 | Welded Repair of Defects Lying on the Inside of Components - The repair of cracks according to the state of the art comprises the fact that defects located on the inside must be worked outward in order to be able to be welded closed. The method according to the invention proposes not to work out cracks located on the inside, but to melt the crack located on the inside utilizing a flux agent. | 05-13-2010 |
20100224600 | TWO-STEP WELDING PROCESS - A welding process is provided. The welding process includes two steps. First, the welding material is applied over a large area of the substrate in the region without melting or partially melting the welding material. Then, a welding device is used to melt the applied welding material. In addition the welding material may be applied in two applications where the second application of the welding material is applied over a large area of the first application of molten and solidified welding material. Then, the second application of the welding material is melted. | 09-09-2010 |
20100269510 | Machine Component and Gas Turbine - A machine component including a base body produced from a base material is provided. The base body is equipped in a partial region of the surface thereof with a plating made of an application material having a greater hardness and/or viscosity as compared to the base material. The plating is foamed by a number of plating elements that are applied to the base body in the longitudinal direction thereof in a tilted manner relative to the main flow direction of a hot gas flowing through the base body. | 10-28-2010 |
20110088482 | Material for tensile and HCF tests for the testing of buildup welds and method - A material specimen is provided. The material specimen for tensile or HCF tests includes two welds arranged opposite one another on the specimen which do not touch. The welds are arranged symmetrically in relation to a plane or mirror symmetrically in relation to a longitudinal axis of the specimen which extends parallel to the line of effective force. | 04-21-2011 |
Patent application number | Description | Published |
20100299766 | MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE QPCTL-GENE - A knock-out non-human animal, in particular a mouse, carrying a QPCTL knock-out mutation. Additionally, respective cells and cell lines and methods and compositions for evaluating agents that affect QPCTL, for use in compositions for the treatment of QPCTL-related diseases are disclosed. | 11-25-2010 |
20120045815 | CRYSTAL STRUCTURE OF GLUTAMINYL CYCLASE - A novel crystal structures of human and murine glutaminyl cyclase (QC, EC 2.3.2.5), methods of preparing the crystals, as well as the use of said crystal structures for identifying inhibitors of human and murine glutaminyl cyclase. | 02-23-2012 |
20130217090 | CRYSTAL STRUCTURE OF GLUTAMINYL CYCLASE - Novel crystal structures of human and murine glutaminyl cyclase (QC, EC 2.3.2.5), methods of preparing the crystals, as well as the use of said crystal structures for identifying inhibitors of human and murine glutaminyl cyclase. | 08-22-2013 |
20130291133 | MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE QPCTL-GENE - A knock-out non-human animal, in particular a mouse, carrying a QPCTL knock-out mutation. Additionally, respective cells and cell lines and methods and compositions for evaluating agents that affect QPCTL, for use in compositions for the treatment of QPCTL-related diseases are disclosed. | 10-31-2013 |
Patent application number | Description | Published |
20080213256 | Less Immunogenic Binding Molecules - The present invention provides a bispecific binding molecule, wherein said molecule comprises or consists of at least two domains whereby one of said at least two domains specifically binds to/interacts with the human CD3 complex and said domain comprises an amino acid sequence of an antibody derived light chain, wherein said amino acid sequence is a particularly identified amino acid sequence comprising specific amino acid substitutions, and a second domain is or contains at least one further antigen-interaction-site and/or at least one further effector domain. The invention further provides nucleic acid molecules encoding the bispecific binding molecules of the invention, vectors comprising said nucleic acid molecules and host cells transformed or transfected with said vectors. Moreover, the invention concerns a method for the production of bispecific binding molecules of the invention and compositions comprising the bispecific binding molecules of the invention, the nucleic acid molecules of the invention or the host cells of the invention. | 09-04-2008 |
20090022738 | Multispecific deimmunized CD3-binders - The present invention provides a cytotoxically active CD3 specific binding construct comprising a first domain specifically binding to human CD3 and an Ig-derived second binding domain. Furthermore, a nucleic acid sequence encoding a CD3 specific binding construct of the invention is provided. Further aspects of the invention are vectors and host cells comprising said nucleic acid sequence, a process for the production of the construct of the invention and composition comprising said construct. The invention also provides the use of said constructs for the preparation of pharmacutical compositions for the treatment of particular diseases, a method for the treatment of particular diseases and a kit comprising the binding construct of the invention. | 01-22-2009 |
20130224205 | MULTISPECIFIC DEIMMUNIZED CD3-BINDERS - The present invention provides a cytotoxically active CD3 specific binding construct comprising a first domain specifically binding to human CD3 and an Ig-derived second binding domain. Furthermore, a nucleic acid sequence encoding a CD3 specific binding construct of the invention is provided. Further aspects of the invention are vectors and host cells comprising said nucleic acid sequence, a process for the production of the construct of the invention and composition comprising said construct. The invention also provides the use of said constructs for the preparation of pharmaceutical compositions for the treatment of particular diseases, a method for the treatment of particular diseases and a kit comprising the binding construct of the invention. | 08-29-2013 |
Patent application number | Description | Published |
20100083853 | DEVICE FOR APPLYING INFORMATION ONTO A SURFACE OF AN AIRCRAFT - The invention relates to a device for applying information onto a surface of an aircraft, wherein the information is applicable in variable locations and is modifiable, comprising the following features:
| 04-08-2010 |
20100086669 | METHOD FOR ACCELERATED DRYING OF POLYMERS AND DEVICE - The invention relates to a method for accelerated drying of at least one polymer which is located at least partially on a component, in particular at least a layer of paint and/or a sealing agent which is applied to an aircraft component in particular with a different material composition, involving the following steps of:
| 04-08-2010 |
20100209618 | METHOD FOR PLASMA TREATMENT AND PAINTING OF A SURFACE - A method for plasma treatment and painting of a surface, the surface including a plurality of different materials includes blasting the surface with a carbon dioxide snow so as to activate the surface to improve an adhesive strength; and treating the surface with a plasma treatment using at least one plasma nozzle following the blasting step, the treating including guiding the at least one plasma nozzle at a distance of not more than 15 mm from the surface at a feed rate of not more than 50 m/min. | 08-19-2010 |
20100304039 | PROCESSING DEVICE AND METHOD FOR COATING A RUDDER UNIT OF AN AIRCRAFT - A processing device for coating a surface of a rudder unit of an aircraft includes a plurality of spatially delimited work stations, wherein each of the plurality of work stations are disposed in succession and are configured to produce an assembly line-like coating process, wherein the plurality of work stations. The work stations include a pretreating station configured to activate the surface so as to form an activated surface; a painting station disposed downstream of the pretreating station and configured to paint the activated surface with at least one layer of paint having a first color so as to form a painted surface and configured to dry the painted surface immediately after the painting; and a decorating station. | 12-02-2010 |
20100316853 | AIRCRAFT WITH PAINTED EXTERIOR SURFACE AND DECORATIVE FILM - An aircraft includes a fuselage having a painted exterior surface having a first color; a decorative film including plastic and having a second color different from the first color and adhesively bonded to the fuselage, wherein the decorative film includes at least one of a polyvinyl fluoride film, a polyester film, a polyvinyl chloride film, a polyethylene film, and a polypropylene film, wherein the decorative film is formable via one of polymerization, polyaddition and polycondensation; and a layer of clear paint containing a UV filter for erosion protection and covering the decorative film. | 12-16-2010 |
20100319618 | DEVICE AND METHOD FOR PRETREATING EXTERIOR SURFACES OF AN AIRCRAFT TO BE PAINTED - A device for pretreating an exterior surface of an aircraft coated with an aircraft-specific base material so as to prepare the surface for a final painting with aircraft paint includes a pretreating tool. The pretreating tool has a laser head configured to activate the aircraft-specific base material using a laser. The device also includes a support construction including a robot device and a control unit configured to control and move the laser head over the surface using the robot device. | 12-23-2010 |
Patent application number | Description | Published |
20090098167 | PHL P 1 Allergen Derivative - Method for producing derivatives of wild-type protein allergen Phl p 1 with reduced allergenic activity compared to the wild-type allergen, comprising the following steps: providing wild-type protein allergen Phl p 1, fragmenting said wild-type protein allergen into at least three fragments, wherein at least one fragment of said at least three fragments comprises at least one T-cell epitope and said at least three fragments have a reduced allergenic activity or lack allergenic activity and rejoining said at least three fragments in an order differing from the order of the fragments in the wild-type allergen. | 04-16-2009 |
20090148466 | Process for the Preparation of Hypoallergenic Mosaic Antigens - A process for the preparation of an hypoallergenic mosaic antigen derived from an allergen is disclosed whereby a) in a first step the allergen is split into at least two parts and the IgE reactivity of each part is determined and b) in a second step those parts of the allergen which have no detectable IgE reaction are combined to a mosaic antigen which comprises the amino acids of the allergen but the order of the amino acids of the mosaic antigen is different from that of the naturally occurring allergen. | 06-11-2009 |
20090324501 | Vaccine Carrier - The present invention relates to a hypoallergenic protein consisting of at least one hypoallergenic molecule derived from an allergen, which is fused or conjugated to at least one second non-allergenic protein or fragment thereof. | 12-31-2009 |
20100203640 | Antigen Presenting Cells - The present invention relates to a method for inducing specific long-lasting robust immunological tolerance towards at least one polypeptide derived from at least one allergen by transplanting a hematopoietic (stem) cell which is produced to display the said at least one polypeptide derived from at least one allergen. | 08-12-2010 |
20110150920 | Allergy Vaccines Containing Hybrid Polypeptides - Hybrid polypeptides comprising at least two different allergenic proteins or fragments thereof wherein each fragment consists of at least eight consecutive amino acids of the respective allergenic protein are disclosed. The hybrid polypeptides and polynucleotides coding therefor can be used as pharmaceutical compositions, in particular as vaccines. | 06-23-2011 |
20120009210 | HYPALLERGENIC MOSAIC ANTIGENS AND METHODS OF MAKING SAME - Hypoallergenic mosaic antigens assembled from naturally-occurring allergens are disclosed herein. Also disclosed are methods of making such hypoallergenic mosaic antigens, particularly those derived from plant allergens such as timothy grass pollen (Phl p 1 and Phl p 2) and birch pollen (Bet v 1). In a particularly preferred embodiment, the method of making the hypoallergenic mosaic antigen involves the steps of (a) cleaving a naturally-occurring allergen into at least two, preferably at least three non-overlapping peptide fragments and (b) recombining the peptide fragments such that the mosaic antigen includes all or substantially all of the amino acids of the original naturally-occurring allergen, though in a different order. | 01-12-2012 |
20120207788 | HYPOALLERGENIC HYBRID POLYPEPTIDES FOR THE TREATMENT OF ALLERGY - The present invention relates to a method for identifying hypoallergenic polypeptides and to a corresponding screening method. The invention further relates to hypoallergenic polypeptides identified by the method of the invention and to the prophylactic and therapeutic use of these polypeptides. | 08-16-2012 |
Patent application number | Description | Published |
20110151218 | SCRATCH RESISTANT TOP COATS HAVING GOOD ADHESION - The present invention relates to a multilayer system comprising a base layer consisting of a thermoplastic, a primer layer, and a scratch resistant layer consisting of a scratch resistant top coat, the multilayer system being characterised in that the primer layer contains a certain UV absorber and a certain amount of acid, preferably acetic acid, is added to the scratch resistant top coat. | 06-23-2011 |
20110293921 | POLYMER COMPOSITION HAVING HEAT-ABSORBING PROPERTIES AND IMPROVED COLOUR PROPERTIES - An embodiment of the present invention relates to a composition comprising a) at least one transparent thermoplastic material; b) at least one inorganic IR absorber comprising at least one boride compound present in an amount of from 0.0015 wt. % to 0.015 wt. %, calculated as solids content of boride in the total polymer composition; and c) at least one inorganic, nano-scale pigment present in an amount of from 0.0008 wt. % to 0.0035 wt. %, based on the total composition; and d) optionally further additives. | 12-01-2011 |
20120094127 | UV ABSORBERS SOLUBLE IN POLAR MEDIA - The invention relates to triazine-based special organic UV absorbers modified in such a way as to be soluble in polar coating compositions. The invention further relates to coatings, e.g. sol-gel based ones, containing said novel UV absorbers as well as to the use of said coatings for permanently protecting materials, especially plastics, from photochemical degradation. | 04-19-2012 |
20120114933 | UV-CURING PROTECTIVE LAYER FOR THERMOPLASTIC SUBSTRATES - The invention relates to a multilayer product containing a first layer (S1) and a second layer (S2). The first layer is a lacquer obtained from A) one or more aliphatic polymer precursors selected from among at least one of the groups comprising components A.1 and A.2, wherein A.1) represents aliphatic oligomers that contain urethane or ester bonds and have at least two acrylate functions per molecule, or mixtures of corresponding oligomers, and A.2) represents aliphatic reactive diluents having at least two acrylate groups per molecule, or mixtures of corresponding reactive diluents, B) one or more fine-particle inorganic compounds, C) at least one organic UV absorber selected from among the group of triazine derivatives and diphenyl triazine derivatives, D) 0.1 to 2 wt. %, relative to the experimentally determined solid content of the mixture of components A, B, and F, of a radical interceptor belonging to the class of basic HALS, E) one or more optional self-leveling agents, F) one or more optional solvents, and G) at least one Norrish type II photoinitiator. The second layer is a thermoplastic polymer. The invention also relates to a lacquer made of the aforementioned components. | 05-10-2012 |
20120135213 | COEXTRUDED FILMS WITH LOW TEMPERATURE IMPACT RESISTANCE - The invention relates to multilayer products comprising a layer (A) and a layer (B), wherein layer (A) contains polyalkyl(alkyl)acrylate and has a layer thickness <25 [mu]m, and layer (B) contains polycarbonate. The total thickness of layers (A) and (B) is 20 to 500 mm. | 05-31-2012 |
20150050484 | POLYMER COMPOSITION HAVING HEAT-ABSORBING PROPERTIES AND IMPROVED COLOUR PROPERTIES - An embodiment of the present invention relates to a composition comprising a) at least one transparent thermoplastic material; b) at least one inorganic IR absorber comprising at least one boride compound present in an amount of from 0.0015 wt. % to 0.015 wt. %, calculated as solids content of boride in the total polymer composition; and c) at least one inorganic, nano-scale pigment present in an amount of from 0.0008 wt. % to 0.0035 wt. %, based on the total composition; and d) optionally further additives. | 02-19-2015 |
Patent application number | Description | Published |
20080261852 | Bleach Reinforcer Combination for Use in Washing and Cleaning Agents - The performance of peroxide compounds, in particular when associated with bleaches for washing ink stains out of textiles, can be improved by a composition comprising: (i) a peroxygen-containing bleaching agent, (ii) a bleach activator selected from the group consisting of amide bleach activators, sulfonyl phenyl ester bleach activators, quaternary nitrogen substituted acetonitrile bleach activators, and mixtures thereof, and (iii) a compound selected from the group consisting of ligands corresponding to the general formula (I), bleach catalysts corresponding to the general formula (II), and mixtures thereof: | 10-23-2008 |
20100022427 | PRODUCT FOR TREATING HARD SURFACES - The invention relates to the use of polycarbonate-, polyurethane-, and/or polyurea-polyorganosiloxane compounds, or precursor compounds thereof containing specific reactive groups, in the treatment of hard surfaces. The treated surface is protected from soiling and/or the removal of soil from the surface is facilitated. | 01-28-2010 |
20100022428 | ANTI-GREY DETERGENT - The invention relates to a detergent which contains a surfactant and optionally further conventional additives of detergents and cleaning agents, the detergent comprising an anti-grey polycarbonate-, polyurethane- and/or polyurea-polyorganosiloxane compound or a precursor compound thereof containing specific reactive groups, which can be used for the production thereof. | 01-28-2010 |
20100041574 | PRODUCT FOR TREATING HARD SURFACES - The invention relates to the use of a product for treating hard surfaces. The product comprises compounds of general formula I or II and polymers that are obtainable by reacting the compounds with polymeric substrates, the substrates having functional groups that are selected from hydroxy groups, primary and secondary amino groups. The treated surface is protected from soiling and/or soil release from the surface is facilitated. | 02-18-2010 |
20110119837 | Washing Agent That Is Gentile on Textiles - Reduction of damage to textiles caused when bleach active catalysts are used when washing the textiles, without influencing bleaching performance. The invention relates to a method for washing textiles in the presence of a peroxygenated bleaching agent and a bleach boosting transition metal complex, wherein the method is carried out when water hardness is between 0° dH-3° dH. | 05-26-2011 |
20120004155 | ANTI-GREY DETERGENT - The invention relates to a detergent which contains a surfactant and optionally further conventional additives of detergents and cleaning agents, the detergent comprising an anti-grey polycarbonate-, polyurethane- and/or polyurea-polyorganosiloxane compound or a precursor compound thereof containing specific reactive groups, which can be used for the production thereof. | 01-05-2012 |
20120005839 | GENTLE BLEACHING AGENT - An agent, and a method that uses the agent, reduces the damage to material containing cellulose during the bleaching thereof, by using a bleaching agent containing peroxygen, a bleach-enhancing transition metal complex, and creatine. | 01-12-2012 |
Patent application number | Description | Published |
20100136039 | BORRELIA ANTIGENS - The present invention relates to isolated nucleic acid molecules which encode a protein, isolated nucleic acid molecules which encode a hyperimmune serum reactive antigen, a vector which comprises such nucleic acid molecule, a host cell comprising such vector, a hyperimmune reactive antigen from | 06-03-2010 |
20100203075 | CHLAMYDIA ANTIGENS - The present invention relates to isolated nucleic acid molecules which encode an antigen from a | 08-12-2010 |
20110236410 | KLEBSIELLA ANTIGENS - The present invention relates to isolated nucleic acid molecules which encode an antigen, a vector which comprises such nucleic acid molecule, and a host cell comprising such vector. Furthermore, the invention provides antigens from a | 09-29-2011 |
20120045457 | NONTYPABLE HAEMOPHILUS INFLUENZAE ANTIGENS - The present invention relates to isolated nucleic acid molecules which encode an antigen from a nontypable | 02-23-2012 |
20120184710 | BORRELIA ANTIGENS - The present invention relates to an isolated nucleic acid molecule encoding a protein, preferably a hyperimmune serum-reactive antigen from | 07-19-2012 |
20130011403 | KLEBSIELLA ANTIGENS - The present invention relates to an isolated nucleic acid molecule encoding an antigen, a vector comprising such nucleic acid molecule and a host cell comprising such vector. Furthermore, the invention provides antigens from | 01-10-2013 |
20130116406 | BORRELIA ANTIGENS - The present invention relates to an isolated nucleic acid molecule encoding a protein, preferably a hyperimmune serum-reactive antigen from | 05-09-2013 |
20130122047 | STREPTOCOCCUS PYOGENES ANTIGENS - The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from | 05-16-2013 |
20130230526 | KLEBSIELLA ANTIGENS - The present invention relates to an isolated nucleic acid molecule encoding an antigen, a vector comprising such nucleic acid molecule and a host cell comprising such vector. Furthermore, the invention provides antigens from | 09-05-2013 |
20140212448 | KLEBSIELLA ANTIGENS - The present invention relates to an isolated nucleic acid molecule encoding an antigen, a vector comprising such nucleic acid molecule and a host cell comprising such vector. Furthermore, the invention provides antigens from | 07-31-2014 |
Patent application number | Description | Published |
20090148463 | IVIG MODULATION OF CHEMOKINES FOR TREATMENT OF MULTIPLE SCLEROSIS, ALZHEIMER'S DISEASE, AND PARKINSON'S DISEASE - The present invention provides methods for providing a prognosis of treatment of diseases associated with inflammatory disease of the brain, including MS, e.g., relapsing-remitting multiple sclerosis (RRMS), Alzheimer's disease, and Parkinson's disease using molecular markers that are shown to be overexpressed or underexpressed in patients treated with intravenous immunoglobulins (IVIG). Also provided are methods to identify compounds that are useful for the treatment or prevention of MS, e.g., relapsing-remitting multiple sclerosis (RRMS), Alzheimer's disease, and Parkinson's disease. | 06-11-2009 |
20090221017 | ANTI-AMYLOID BETA ACTIVITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN VITRO - The present invention relates to a cell-based in vitro screening assay for identifying and selecting therapeutic agents that inhibit amyloid r-induced cytotoxicity. | 09-03-2009 |
20130177933 | Characterization of Subvisible Particles Using a Particle Analyzer - The present specification discloses methods of characterizing a population of particles using a particle analyzer. Particles may be characterized by size, absolute number, whether the particle is non-proteinaceous or proteinaceous, whether a proteinaceous particle has or lacks a certain physical property, or any combination thereof. | 07-11-2013 |